If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 117.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.426%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 117.50
RECI Live PriceLast checked at -
Real Estate Credit Investments is an Investment Trust

To provide attractive and stable returns, primarily through quarterly dividends, by exposure to a diversified portfolio of real estate credit investments, predominantly comprising real estate loans and bonds, focusing in UK and Western Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment Manager's Q2 Investor Presentation

27 Oct 2022 10:00

RNS Number : 3318E
Real Estate Credit Investments Ltd
27 October 2022
 

27 October 2022

 

Real Estate Credit Investments Limited

 

Investment Manager's Q2 Investor Presentation

 

Real Estate Credit Investments Limited ("RECI" or "the Company") is pleased to announce that the Investment Manager's Q2 Investor Presentation is now available on the Company's website at:

 

https://www.recreditinvest.com/investors/results-reports-and-presentations/#currentPage=1

 

An extract from the Summary section of the presentation is set out for investors in the Appendix to this announcement.

 

For further information, please contact:

 

Broker: Richard Crawley / Darren Vickers (Liberum Capital) +44 (0)20 3100 2222

Investment Manager: Richard Lang (Cheyne) +44 (0)20 7968 7328

 

 

Appendix: Q2 Investor Presentation Extract

 

Key Quarter Updates

Portfolio

- 1 new deal completed (£18.7m of commitments) since 30 June 2022

- No defaults in the portfolio

- Continued migration of portfolio to senior lending

Cash

- Cash reserves remain targeted at between 5% to 10% of NAV

Dividend

- Dividends maintained at 3p per quarter, 8.9% yield, based on share price, as at 30 September 2022

Financing

- Employs a mix of flexible, short-dated financing alongside term-matched structured financing on selected high-quality senior loan deals

Opportunities

- The present crisis is set to continue through 2023, resulting in further constraints in bank lending and alternative sources of capital. The opportunity to provide senior loans at low risk points, for higher margins, is increasingly compelling

- The core European CMBS markets are experiencing market price declines due to increasing indiscriminate selling, presenting opportunities in the market

- The Company expects to deploy its currently available cash resources to its near term commitments and to build cash resources towards a very compelling emerging opportunity set in both senior loans and bonds

 

 

 

 

ü Attractive returns from defensive, Senior, low LTV credit exposure to UK and European commercial real estate assets

A focus on Senior, 1st lien loans : Senior, 1st Lien, Loans now account for 87% of the book by value. This is anticipated to be 89% as mezzanine loans repay. Top 10 positions are 100% Senior Loans. New origination is 100% Senior

Weighted Average LTV on underlying investments of 60.4% as at 30 September 2022

Predominantly large, well capitalised, and experienced institutional borrowers

Minimal exposure to Shopping Centers (

RECI retains absolute governance, covenants and control, afforded by Senior ranking and bilateral singular lending relationships

Portfolio has withstood COVID19 and is well place to withstand the current revaluations in real estate

ü Quarterly dividends delivered consistently since October 2013

The Company has consistently sought to pay a stable quarterly dividend from its distributable profits

This has led to a stable annualised dividend of around 7% of NAV

ü Highly granular book

62 positions

ü Transparent and conservative leverage

Net leverage 26.9% (with £27.4m cash) as at 30 September 2022 versus a leverage limit of 40%

Non-recourse and limited-recourse, term, structured finance provides returns optimisation and financial flexibility on senior loans

Access to established real estate investment team at Cheyne, which manages c$5bn AUM

ü Access to pipeline of enhanced return investment opportunities identified by Cheyne

ü Robust mitigation against a rising rates environment

A high yielding portfolio, combined with a short weighted average life of under 2 years, ensures minimal exposure to yield widening and the ability to redeploy quickly at higher rates

Pipeline is 100% floating rate senior loans

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDVDLBLLBLFFBE
Date   Source Headline
6th Feb 201711:36 amRNSNotification of Major Interest in Shares
6th Jan 20177:00 amRNSFact Sheet Announcement
7th Dec 20167:00 amRNSFact Sheet Announcement
30th Nov 20167:00 amRNSDividend Declaration - Preference Dividend
30th Nov 20167:00 amRNSDividend Declaration - Ordinary Dividend
30th Nov 20167:00 amRNSCondensed Interim Financial Report
30th Nov 20167:00 amRNSHalf-year Report
3rd Nov 20167:00 amRNSFact Sheet Announcement
25th Oct 201611:30 amRNSChange of Name
5th Oct 20167:00 amRNSFact Sheet Announcement
16th Sep 20162:00 pmRNSResult of AGM
7th Sep 20167:00 amRNSFact Sheet Announcement
18th Aug 20167:00 amRNSNotice of AGM
10th Aug 20163:00 pmRNSDividend Declaration - Preference Dividend
10th Aug 20163:00 pmRNSDividend Declaration - Ordinary Dividend
9th Aug 20167:00 amRNSFact Sheet Announcement
22nd Jul 20165:00 pmRNSDirector Declaration
12th Jul 20162:00 pmRNSDirector/PDMR Shareholding
7th Jul 201612:00 pmRNSFact Sheet Announcement
4th Jul 20167:00 amRNSDirector Declaration - Additional Directorship
1st Jul 201612:07 pmRNSDirectorate Change
17th Jun 20167:00 amRNSDividend Declaration - Ordinary Dividend
17th Jun 20167:00 amRNSFinal Results
17th Jun 20167:00 amRNSAnnual Financial Report
9th Jun 20167:00 amRNSDividend Declaration - Preference Dividend
7th Jun 20167:00 amRNSFact Sheet Announcement
31st May 20167:00 amRNSNotice of Resuts
6th May 20167:00 amRNSFact Sheet Announcement
13th Apr 201610:00 amRNSDirector/PDMR Shareholding
8th Apr 201611:33 amRNSFact Sheet Announcement
21st Mar 20162:00 pmRNSAppointment of New Director
18th Mar 20167:00 amRNSReturn of Capital to Cell Shareholders
4th Mar 20167:00 amRNSFact Sheet Announcement
10th Feb 20167:00 amRNSDividend Declaration - Ordinary Dividend
10th Feb 20167:00 amRNSDividend Declaration - Preference Dividend
3rd Feb 20167:00 amRNSFact Sheet Announcement
13th Jan 20169:56 amRNSDirector/PDMR Shareholding
6th Jan 20167:00 amRNSFact Sheet Announcement
7th Dec 20157:00 amRNSFact Sheet Announcement
27th Nov 20157:00 amRNSPreference Dividend Declaration
27th Nov 20157:00 amRNSOrdinary Dividend Declaration
27th Nov 20157:00 amRNSCondensed Interim Financial Report
27th Nov 20157:00 amRNSHalf Year Results
12th Nov 20157:00 amRNSNotice of Results
4th Nov 20157:00 amRNSFact Sheet Announcement
20th Oct 20154:40 pmRNSNew directorship notification under Listing Rules
19th Oct 20157:00 amRNSCompany Update
13th Oct 201512:28 pmRNSDirector/PDMR Shareholding
5th Oct 201512:00 pmRNSFact Sheet Announcement
4th Sep 20157:00 amRNSFact Sheet Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.